Long-term cannabis smoking affects nearly every major organ system, though the severity depends heavily on how much you use, how early you started, and how you consume it. The lungs, heart, brain, and mental health bear the clearest risks, while subtler effects touch metabolism, fertility, oral health, and gut function. Some of these changes reverse with abstinence; others, particularly those rooted in adolescent use, appear more durable. The picture is more complicated than either side of the legalization debate typically lets on.
Lungs and Airways
Smoking cannabis irritates the airways much the way tobacco smoke does. Chronic users commonly develop a persistent cough, increased phlegm, wheezing, and episodes of bronchitis. A review of the mechanistic and epidemiological evidence found that these symptoms often resemble chronic bronchitis and tend to resolve after quitting, which suggests the damage is inflammatory rather than permanent structural destruction.1PubMed Central. Cannabis use and its impact on respiratory physiology and lung cancer risk: Mechanistic and epidemiological insights That same body of work notes that, unlike tobacco, cannabis does not consistently cause emphysema, though heavy, prolonged use can lead to airflow obstruction.
Occasional use at low cumulative levels does not appear to be a meaningful risk factor for chronic obstructive pulmonary disease. Heavy use alone, however, can produce measurable airflow limitation.2PubMed. Marijuana and lung diseases The practical takeaway is that light, infrequent smoking probably does not leave lasting lung scars, but years of daily joints put you in a different category.
Lung Cancer Risk
Whether cannabis smoking causes lung cancer has been debated for decades, and the evidence has grown stronger in a concerning direction. A case-control study from New Zealand found that lung cancer risk rose about 8% for each “joint-year” of cannabis smoking (one joint per day for one year) after adjusting for cigarette smoking and other variables. The heaviest users in that study had a roughly sixfold increase in risk compared to nonusers.3PubMed Central. Cannabis use and risk of lung cancer: a case-control study
A more recent retrospective cohort study reinforced those findings from a different angle. People with cannabis use disorder had about four times the risk of developing lung or bronchus cancer compared to matched individuals without the disorder, and that elevated risk held across all major cancer subtypes examined, including small cell carcinoma and adenocarcinoma.4PubMed. Association of cannabis use and lung cancer: a retrospective cohort study It is worth noting that cannabis use disorder represents the heavy end of the spectrum, not casual weekend use. Still, the association is not trivial, and the fact that it spans multiple cancer types makes a coincidental finding less plausible.
Heart and Blood Vessels
Cardiovascular risk is one of the less intuitive long-term effects, since most people associate cannabis with relaxation rather than heart trouble. But data from large U.S. surveys tells a different story. In a study of adults aged 18 to 74, daily cannabis use was linked to roughly 25% higher odds of heart attack and about 40% higher odds of stroke, even after controlling for tobacco. Among people who had never smoked tobacco, daily cannabis use was associated with about double the odds of stroke.5PubMed Central. Association of Cannabis Use With Cardiovascular Outcomes Among US Adults The risk scaled with frequency: the more days per month a person used cannabis, the higher the odds of a cardiovascular event.
A separate analysis from a Minnesota healthcare system found that cannabis users had about a 40% higher risk of death from any cause, a 25% higher risk of stroke, and about a 50% higher risk of heart attack compared to nonusers, after adjusting for other substance use and potential confounders.6Circulation. Abstract P2024: The Association of Cannabis Use with Risk of Mortality, Incident Stroke, and Incident Myocardial Infarction in a Minnesota Healthcare System, 2016-2023 These are observational findings, so they cannot prove causation on their own. But the consistency across multiple large datasets and the dose-response pattern make the signal hard to dismiss.
Brain Structure and Cognition
The question of whether cannabis shrinks or damages the brain has generated contradictory results, and the answer depends on what you measure and who you study. Two longitudinal studies found no significant differences in hippocampal volume between cannabis users and controls. One tracked heavy users over time and found that their hippocampi grew at the same rate as nonusers’.7PubMed Central. Longitudinal study of hippocampal volumes in heavy cannabis users Another, using data from a large U.S. cohort followed into middle age, found no association between cumulative cannabis use and hippocampal volume, blood flow, or white matter integrity among people who had never smoked tobacco.8Translational Psychiatry. Cumulative exposure to cannabis and hippocampus MRI in middle age: results from the coronary artery risk development in young adults (CARDIA) study
Yet other research paints a grimmer picture. A study comparing current heavy users, former users, and controls found that users of cannabis low in CBD had hippocampi about 11% smaller than those of nonusers. Users whose cannabis contained more CBD showed less severe reductions, and former users who had quit did not differ significantly from controls, suggesting recovery is possible.9PubMed Central. Hippocampal harms, protection and recovery following regular cannabis use The composition of what you smoke, particularly its CBD content, seems to matter for how much structural damage accrues.
On the receptor level, chronic daily smoking reduces the availability of CB1 receptors in the brain’s cortical regions by roughly 20%. The longer someone had been smoking, the greater the reduction. The encouraging news: after about a month of monitored abstinence, receptor levels in most regions bounced back toward normal.10PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers A separate study found that group differences in receptor availability between dependent users and controls disappeared after just two days of abstinence.11PubMed Central. Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis
Why Starting Young Changes Things
The adolescent brain is still under construction, and cannabis appears to interfere with that process in ways that adult use does not. A landmark study following participants from childhood to age 38 found that persistent cannabis use was associated with broad neuropsychological decline, and the damage was concentrated among those who began using before age 18. The more persistently they used, the larger the IQ drop. Critically, quitting did not fully restore cognitive function in this group.12PubMed Central. Persistent cannabis users show neuropsychological decline from childhood to midlife
Multiple studies converge on the same pattern. Teens who started before age 15 or 16 performed worse on tasks of attention, impulse control, verbal memory, and executive functioning compared to later-onset users.13PubMed Central. Effects of Cannabis on the Adolescent Brain Both animal and human data support the idea that the developing brain is simply more vulnerable: adolescent exposure produces more severe cognitive impairment than adult exposure at comparable levels of use.14Biological Psychiatry Global Open Science. Cannabis Use in Adolescence: Vulnerability to Cognitive and Psychological Effects This is one of the most consistent findings in the cannabis research literature and one of the strongest arguments for keeping cannabis away from teenagers regardless of legality.
Mental Health Risks
The link between cannabis and psychosis is among the best-established mental health findings. Longitudinal studies consistently show that regular use predicts a higher risk of schizophrenia and psychotic symptoms, even after accounting for other drug use and personal characteristics.15PubMed Central. Cannabis use and the risk of developing a psychotic disorder High-potency cannabis and daily use both amplify that risk further. Not everyone who smokes will develop psychosis, of course, but for genetically vulnerable people, cannabis can be the trigger that tips them over.
Genetics play a documented role in who is most at risk. A systematic review of genetic polymorphisms found that variations in genes tied to dopamine pathways, particularly the COMT gene (specifically the Val allele at one key location) and the AKT1 gene (the CC genotype at another), are associated with higher susceptibility to cannabis-induced psychosis.16PubMed. Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms You cannot practically test yourself for these variants before deciding whether to use cannabis, but the finding underscores that psychosis risk is not evenly distributed across the population. A family history of schizophrenia or psychotic episodes is a meaningful red flag.
Depression and motivation get muddier. A population-based longitudinal study of people with major depressive disorder found that while cannabis users had more depressive symptoms at follow-up, the associations between cannabis and things like suicidality, daily functioning, and quality of life largely disappeared once baseline factors like other substance use and sociodemographic differences were controlled for.17PubMed. Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study As for the “lazy stoner” stereotype, a comprehensive review found that the correlations between cannabis use and low motivation were small and mostly explained by co-occurring depression, alcohol use, and personality traits. The one exception: people who misuse cannabis did show higher levels of apathy even after controlling for those confounders.18PubMed. A Comprehensive Examination of the Links between Cannabis Use and Motivation
Metabolic Effects
Cannabis and metabolism have a paradoxical relationship that surprises most people. A large cross-sectional analysis of U.S. adults found that current cannabis users had about 16% lower fasting insulin levels and 17% lower insulin resistance compared to people who had never used, along with slightly higher HDL (“good”) cholesterol.19The American Journal of Medicine. The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults A separate study looking at lean, overweight, and obese adults found that obese current users had substantially lower fasting insulin than obese never-users, and this benefit persisted even years after quitting.20PubMed. Lifetime marijuana use in relation to insulin resistance in lean, overweight, and obese US adults
Before you conclude cannabis is metabolically protective, though, a controlled study comparing chronic cannabis smokers to matched controls found that smokers had more visceral belly fat and worse fat-cell insulin resistance, despite having similar overall body fat percentages. Their blood sugar handling was not impaired, but the pattern in their fat tissue was not healthy.21PubMed Central. Metabolic effects of chronic cannabis smoking So the metabolic story is genuinely mixed: population-level data shows favorable insulin markers, but closer examination reveals unfavorable changes in where and how fat is stored. Researchers have not fully reconciled these findings.
Fertility and Pregnancy
For men, the strongest evidence of harm concerns sperm. A systematic review found that cannabis reduces sperm count and concentration, impairs sperm shape and motility, and interferes with the biochemical changes sperm undergo before fertilization. Animal studies also show testicular atrophy and reduced sex drive, though those specific results have not been confirmed in humans. Effects on testosterone are inconclusive.22PubMed Central. Cannabis and Male Fertility: A Systematic Review
For pregnant women, the picture is nuanced. A systematic review found that cannabis use during pregnancy was associated with a range of effects in offspring, including sleep disturbances, tremors, memory and perception problems in childhood, higher rates of aggression and distraction in toddlers, and signs of depression and anxiety by age two. Heavier use in the first trimester correlated with more frequent problems. By school age, learning difficulties appeared, with some evidence of behavioral issues persisting into the teenage years.23European Journal of Midwifery. Cannabis use during pregnancy and its effect on the fetus, newborn and later childhood: A systematic review However, a large cohort study that specifically looked at speech and language disorders, global developmental delays, and motor delays found no association with maternal prenatal cannabis use for any of those outcomes.24JAMA Network Open. Early Maternal Prenatal Cannabis Use and Child Developmental Delays The effects that do appear tend to be behavioral and emotional rather than straightforward developmental milestones.
Teeth, Gums, and the Gut
Oral health is a surprisingly well-documented casualty of long-term cannabis smoking. A study of young adults found that heavy cannabis exposure roughly tripled the risk of having a site with significant gum attachment loss, independent of tobacco smoking, dental hygiene habits, and plaque levels.25PubMed Central. Cannabis smoking and periodontal disease among young adults Periodontal disease matters beyond aesthetics: unchecked gum breakdown can lead to tooth loss and is itself linked to cardiovascular problems.
On the gastrointestinal side, a condition called cannabinoid hyperemesis syndrome (CHS) deserves mention. CHS produces cycles of severe nausea and uncontrollable vomiting in long-term, heavy users. A hallmark is that sufferers compulsively take hot showers or baths, sometimes more than a dozen a day, because heat provides temporary relief. One well-documented case involved a man who endured 16 years of these attacks before quitting cannabis, which led to a complete and lasting resolution of symptoms over nine years of follow-up.26PubMed Central. Case of cannabinoid hyperemesis syndrome with long-term follow-up CHS is still underdiagnosed, partly because patients and clinicians do not always connect vomiting with a drug most people associate with appetite stimulation.
Sleep Disruption During Withdrawal
Many long-term users report that cannabis helps them sleep, and it often does in the short term. The problem surfaces when you stop. A controlled study found that abrupt cessation of daily use disrupted both how quickly people fell asleep and the architecture of their sleep, with particular disturbances to REM sleep.27PubMed Central. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal For many people trying to quit, insomnia and vivid, disturbing dreams are the withdrawal symptoms that drive relapse. The sleep disruption is real and measurable, not just subjective complaint, and it can persist for weeks.
What Recovers After You Quit
One of the most common questions long-term users have is whether the damage is permanent. The answer varies by system. Respiratory symptoms like chronic cough and bronchitis tend to clear up after cessation. CB1 receptor availability in the brain, as discussed earlier, normalizes within days to weeks. Hippocampal volume and neurochemical markers appear to recover in former users who abstain long enough.9PubMed Central. Hippocampal harms, protection and recovery following regular cannabis use
Cognitive performance tells a similar story for adults. A study that tracked cannabis users through unrestricted use, short-term abstinence, and extended abstinence beyond 90 days found that cognitive and motor impairments visible during early abstinence were no longer detectable after three months off.28PubMed Central. Residual and enduring effects of cannabis use on cognitive and psychomotor function: A study of adults during unrestricted cannabis use, short-term abstinence, and protracted abstinence Preliminary neuroimaging work has shown some improvement in brain blood flow and working memory after six months of abstinence, though the data remain early-stage.29PubMed Central. Brain Function and Marijuana: Are there Changes after Abstinence of Consumption? Preliminary Results
The major caveat is adolescent-onset use. The study that followed persistent users from childhood to midlife found that quitting did not fully restore neuropsychological function in people who had started as teenagers.12PubMed Central. Persistent cannabis users show neuropsychological decline from childhood to midlife For adults who started later, the prognosis for recovery looks substantially better.
Does Vaping Change the Risk Profile
Vaporizing cannabis rather than smoking it reduces exposure to carbon monoxide and several combustion-related toxins while delivering similar blood levels of THC.30PubMed Central. Are vaporizers a lower-risk alternative to smoking cannabis? Chronic respiratory symptoms like cough and phlegm appear to improve when smokers switch to vaporizers, which makes sense given that you are removing the combustion step responsible for most airway irritation.
But vaping is not a clean pass. Both methods produce comparable acute effects on heart rate and blood pressure. THC vaping has been clearly linked to e-cigarette or vaping-associated lung injury, and vapers still report respiratory symptoms. Long-term data on whether vaping cannabis carries risks of chronic lung disease, cancer, or cardiovascular events comparable to smoking simply do not exist yet.31PubMed. Health impacts of cannabis: focus on smoking vs. vaping effects on the respiratory and cardiovascular systems Vaping likely reduces some respiratory harms but does not eliminate the cardiovascular, cognitive, or mental health risks driven by THC itself rather than by smoke.